/ In Vitro Diagnostics
BG Medicine has licensed Abbott rights to intellectual property related to the galectin-3 biomarker for heart failure. (Nov.)
Deals Shaping the Medical Industry (12/2009)
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.